Atopic dermatitisReview of comorbidities and therapeutics

Ann Allergy Asthma Immunol. 2022 Aug;129(2):142-149. doi: 10.1016/j.anai.2022.05.015. Epub 2022 May 21.


Atopic dermatitis (AD) is a very common skin disease associated with substantial burdens on patient health and quality of life. Knowledge regarding the pathogenesis of AD has expanded within recent years, leading to novel and efficacious therapeutic agents. Similarly, our knowledge of the impact of AD on patient's mental and physical health has also expanded. This review summarizes updates on the evolution, comorbidities, and therapeutic options of AD. AD is associated with increased cardiovascular risk, allergic diseases, and adverse mental health outcomes. Topical and systemic therapeutics have drastically altered the landscape of AD therapy in recent years.

Publication types

  • Review

MeSH terms

  • Comorbidity
  • Dermatitis, Atopic* / drug therapy
  • Dermatitis, Atopic* / epidemiology
  • Humans
  • Quality of Life*